Amgen AMGN
NASDAQ AMGN
$377.33 -5.14 (-1.34%)
As of: Sep 11, 2026 · 3:59 PM EDT

Amgen (AMGN) Dividends Paid - Common (2011 - 2026)

Amgen (AMGN) posted Dividends Paid - Common of $1.4 billion for Q2 2026, little changed on a QoQ basis from $1.4 billion in Q1 2026, and up 6.41% year-over-year from $1.3 billion in Q2 2025.

Analysis

Amgen (AMGN) Dividends Paid - Common (2011 - 2026) Analysis & Trends

Amgen has reported Dividends Paid - Common for 16 years, with the latest figure at $1.4 billion in Q2 2026.

  • On a quarterly basis, Dividends Paid - Common rose 6.41% year-over-year to $1.4 billion in Q2 2026; TTM through Jun 2026 was $5.3 billion, a 6.25% increase from a year earlier, with the FY2025 full-year figure at $5.1 billion, up 6.04% from the prior year.
  • Dividends Paid - Common was $1.4 billion for Q2 2026 at Amgen, roughly flat from $1.4 billion in the prior quarter.
  • The five-year high for Dividends Paid - Common was $1.4 billion in Q2 2026, with the low at $1.0 billion in Q2 2022.
  • Average Dividends Paid - Common over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: Dividends Paid - Common advanced 2.98% in 2022, then advanced 9.83% in 2023.
  • Over 5 years, Dividends Paid - Common stood at $1.0 billion in 2022, then increased by 9.62% to $1.1 billion in 2023, then rose by 5.7% to $1.2 billion in 2024, then advanced by 6.47% to $1.3 billion in 2025, then grew by 6.16% to $1.4 billion in 2026.
  • The last three Dividends Paid - Common figures came in at $1.4 billion (Q2 2026), $1.4 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn 1.36 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn 1.03 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 96.80 Mn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn -
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn -
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn -
10 Insmed 28.06 Bn 26.90 Bn 358.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.36 Bn
Mar 31, 2026 1.36 Bn
Dec 31, 2025 1.28 Bn
Sep 30, 2025 1.28 Bn
Jun 30, 2025 1.28 Bn
Mar 31, 2025 1.28 Bn
Dec 31, 2024 1.21 Bn
Sep 30, 2024 1.21 Bn
Jun 30, 2024 1.21 Bn
Mar 31, 2024 1.21 Bn
Dec 31, 2023 1.14 Bn
Sep 30, 2023 1.14 Bn
Jun 30, 2023 1.14 Bn
Mar 31, 2023 1.14 Bn
Dec 31, 2022 1.04 Bn
Sep 30, 2022 1.04 Bn
Jun 30, 2022 1.04 Bn
Mar 31, 2022 1.08 Bn
Dec 31, 2021 990.00 Mn
Sep 30, 2021 999.00 Mn